Evaluating the biological effects of pre-operative intravenous administration of JX-594 (thymidine kinase-deactivated Vaccinia virus plus GM-CSF) prior to planned surgical resection of locally advanced/poor prognosis or metastatic cancers Lay summary under review with external organisation

• Pays Aucun
• Organes Aucun
• Spécialités Aucune